Shi, from the same research team as Zhou, reported that high ABHD5 expression is associated with poor overall survival (OS) in endometrial cancer patients, as confirmed by univariate and multivariate Cox regression analyses. This evidence concerns the gene ABHD5 and endometrial cancer.